Higher parity and earlier age at first birth are associated with lower risk of death from colon cancer

Cancer Science

Volumn 103, Issue 8, 2012, Pages 1553-1557

  Kuo, Chao Hung ^a   Kuo, Chien Chun ^b   Wu, Hsiu Yi ^a   Wu, Deng Chyang ^a   Yang, Chun Yuh ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER MORTALITY; CANCER RISK; CHILDBIRTH; COLON CANCER; FEMALE; FOLLOW UP; HAZARD RATIO; HEREDITY; HUMAN; LIVE BIRTH; MAJOR CLINICAL STUDY; PARITY; PRIORITY JOURNAL;

COLONIC NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MATERNAL AGE; PARITY; PREGNANCY; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SURVIVAL RATE; TAIWAN;

EID: 84864323969     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2012.02336.x     Document Type: Article

References (45)

1. Department of Health. Statistics of Causes of Death. Taipei: Department of Health, 2011.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics. CA Cancer J Clin 2005; 55: 74-108.
3. Fraumeni JF, Lloyd JW, Smith EM, Wagoner JK. Cancer mortality among nuns: role of marital status in the etiology of neoplastic disease in women. J Natl Cancer Inst 1969; 42: 455-68.
4. McMichael AJ, Potter JD. Reproduction, endogenous and exogenous sex hormones, and colon cancer: a review and hypothesis. J Natl Cancer Inst 1980; 65: 1201-7.
5. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the estrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 1994; 7: 536-40.
6. Foley EF, Jazaeri AA, Shupnik MA, Jazaeri O, Rice LW. Selective loss of estrogen receptor B in malignant human colon. Cancer Res 2000; 60: 245-8.
7. B isoforms in colon cancer. Cancer Res 2001; 61: 632-40.
8. Odagiri E, Jibiki K, Kato Y et al. Steroid receptors in dimethylhydrazine-induced colon carcinogenesis. Cancer 1985; 56: 2627-34.
9. Smirnoff P, Liel Y, Gnainsky J, Shany S, Schwartz B. The protective effect of estrogen against chemically induced murine colon carcinogenesis is associated with decreased CpG island methylation and increased mRNA and protein expression of the colonic vitamin D receptor. Oncol Res 1999; 11: 255-64.
10. Chlebowski RT, Wactawski-Wende J, Ritenbaugh C et al. Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med 2004; 350: 991-1004.
11. Gunter MJ, Hoover DR, Yu H et al. Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women. Cancer Res 2008; 68: 329-37.
12. Clendenen TV, Koenig KL, Shore RE, Levitz M, Arslan AA, Zeleniuch-Jacquotte A. Postmenopausal levels of endogenous sex hormones and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2009; 18: 275-81.
13. Zervoudakis A, Strickler HD, Park Y et al. Reproductive history and risk of colorectal cancer in postmenopausal women. J Natl Cancer Inst 2011; 103: 826-34.
14. Wu AH, Paganini-Hill A, Ross RK, Henderson BE. Alcohol, physical activity and other risk factors for colorectal cancer: a prospective study. Br J Cancer 1987; 55: 687-94.
15. Kravdal O, Glattre E, Kvale G, Tretli S. A sub-site-specific analysis of the relationship between colorectal cancer and parity in complete male and female Norwegian birth cohorts. Int J Cancer 1993; 53: 56-61.
16. Tamakoshi K, Wakai K, Kojima M et al. A prospective study on the possible association between having children and colon cancer risk: findings from the JACC Study. Cancer Sci 2004; 95: 243-7.
17. Chute CG, Willett WC, Colditz GA, Stampfer MJ, Rosner B, Speizer FE. A prospective study of reproductive history and exogenous estrogens on the risk of colorectal cancer in women. Epidemiology 1991; 2: 201-7.
18. Kvale G, Heuch I. Is the incidence of colorectal cancer related to reproduction? A prospective study of 63, 000 women Int J Cancer 1991; 47: 390-5.
19. Troisi R, Schairer C, Chow WH, Schatzkin A, Brinton LA, Fraumeni JF. Reproductive factors, oral contraceptive use, and risk of colorectal cancer. Epidemiology 1997; 8: 75-9.
20. Martinez ME, Grodstein F, Giovannucci E et al. A prospective study of reproductive factors, oral contraceptive use, and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 1997; 6: 1-5.
21. van Wayenburg CA, van der Schouw YT, van Noord PA, Peeters PH. Age at menopause, body mass index, and the risk of colorectal cancer mortality in the Dutch Diagnostisch Onderzoek Mammacarcinoom (DOM) cohort. Epidemiology 2000; 11: 304-8.
22. Tamakoshi K, Wakai K, Kojima M et al. A prospective study of reproductive and menstrual factors and colon cancer risk in Japanese women: findings from the JACC Study. Cancer Sci 2004; 95: 602-7.
23. Lin J, Zhang SM, Cook NR, Manson JE, Buring JE, Lee IM. Oral contraceptives, reproductive factors, and risk of colorectal cancer among women in a prospective cohort study. Am J Epidemiol 2007; 165: 794-801.
24. Kabat GC, Miller AB, Rohan TE. Oral contraceptive use, hormone replacement therapy, reproductive history and risk of colorectal cancer in women. Int J Cancer 2008; 122: 643-6.
25. Akhter M, Inoue M, Kurahashi N, Iwasaki M, Sasazuki S, Tsugane S. Reproductive factors, exogenous female hormone use and colorectal cancer risk: the Japan public health center-based prospective study. Eur J Cancer Prev 2008; 17: 515-24.
26. Potter JD, Hunter D. Colorectal cancer. In: Adami HO, Hunter D, Trichopoulos D, eds. Textbook of Cancer Epidemiology, 2nd edn. New York: Oxford University Press, 2008: 275-307.
27. Yang CY, Kuo HW, Chiu HF. Age at first birth, parity, and risk of death from ovarian cancer in Taiwan: a country of low incidence of ovarian cancer. Int J Gynecol Cancer 2007; 17: 32-6.
28. Wu CH, Chan TF, ChangChien CC, Yang CC. Parity, age at first birth, and risk of death from liver cancer: evidence from a cohort in Taiwan. J Gastroenterol Hepatol 2011; 26: 334-9.
29. Yen SS. Endocrinology of pregnancy. In: CreasyRK, Resnik R, eds. Maternal-Fetal Medicine: Principles and Practice, 3rd edn. Philadelphia, PA: Saunders, 1994; 382-412.
30. Qiu Y, Waters CE, Lewis AE, Lanqman MJ, Eqqo MC. Oestrogen-induced apotosis in colonocytes expressing oestrogen receptor beta. J Endocrinol 2002; 174: 369-77.
31. Newcomb PA, Pocobelli G, Chia V. Why hormones protect against large bowel cancer: old ideas, new evidence. Adv Exp Med Biol 2008; 617: 259-69.
32. Sandler DP, Wilcox AJ, Horney LF. Age at menarche and subsequent reproductive events. Am J Epidemiol 1984; 119: 765-74.
33. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993; 15: 36-47.
34. Chavez-MacGregor M, Elias SG, Onland-Moret NC et al. Postmenopausal breast cancer risk and cumulative number of menstrual cycles. Cancer Epidemiol Biomarkers Prev 2005; 14: 799-804.
35. Chen YH, Chen KY, Lin HC. Non-alcoholic cirrhosis and the risk of stroke: a five-year follow-up study. Liver Int 2011; 31: 354-60.
36. Hyodo I, Suzuki H, Takahashi K et al. Present status and perspectives of colorectal cancer in Asia: colorectal Cancer Working Group Report in 30th Asia-Pacific Cancer Conference. Jpn J Clin Oncol 2010; 40(Suppl 1): i38-43.
37. Ju JH, Chang SC, Wang HS et al. Changes in disease pattern and treatment outcome of colorectal cancer: a review of 5474 cases in 20 years. Int J Colorectal Dis 2007; 22: 855-62.
38. Fernandez E, La Vecchia C, Balducci A, Chatenoud L, Franceschi S, Negri E. Oral contraceptives and colorectal cancer risk: a meta-analysis. Br J Cancer 2001; 84: 722-7.
39. Hebert-Croteau N. A meta-analysis of hormone replacement therapy and colon cancer in women. Cancer Epidemiol Biomarkers Prev 1998; 7: 653-9.
40. Grodstein F, Newcomb PA, Stampfer RJ. Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Epidemiol 1999; 106: 574-82.
41. Chie WC, Chung YL, Huang CS, Chang KJ, Yen ML, Lin RS. Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives. Int J Cancer 1998; 77: 219-23.
42. Yen ML, Yen BL, Bai CH, Lin RS. Risk factors for ovarian cancer in Taiwan: a case-control study in a low-incidence population. Gynecol Oncol 2003; 89: 318-24.
43. Lai JN, Wu CT, Chen PC, Huang CS, Chow SN, Wang JD. Increased risk for invasive breast cancer associated with hormonal therapy: a nation-wide random sample of 65, 723 women followed from 1997 to 2008. PLoS One 2011; 6: e25183.
44. Tsilidis KK, Allen NE, Key TJ et al. Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European prospective investigation into cancer and nutrition. Br J Cancer 2011; 105: 1436-42.
45. Benson VS, Pirie K, Green J et al. Hormonal replacement therapy and incidence of central nervous system tumors in the million women study. Int J Cancer 2010; 127: 1692-8.